• About
  • Masthead
  • License Content
  • Advertise
  • Submit Press Release
  • RSS/Email List
  • 2MM Podcast
  • Write for us
  • Contact Us
2 Minute Medicine
No Result
View All Result

No products in the cart.

SUBSCRIBE
  • Specialties
    • All Specialties, All Recent Reports
    • Cardiology
    • Chronic Disease
    • Dermatology
    • Emergency
    • Endocrinology
    • Gastroenterology
    • Imaging and Intervention
    • Infectious Disease
    • Nephrology
    • Neurology
    • Obstetrics
    • Oncology
    • Ophthalmology
    • Pediatrics
    • Pharma
    • Preclinical
    • Psychiatry
    • Public Health
    • Pulmonology
    • Rheumatology
    • Surgery
  • Tools
    • EvidencePulse™
    • RVU Search
    • NPI Registry Lookup
  • Pharma
  • AI News
  • The Scan+
  • Classics™+
    • 2MM+ Online Access
    • Paperback and Ebook
  • Rewinds
  • Partners
    • License Content
    • Submit Press Release
    • Advertise with Us
  • Account
    • Subscribe
    • Sign-in
    • My account
2 Minute Medicine
  • Specialties
    • All Specialties, All Recent Reports
    • Cardiology
    • Chronic Disease
    • Dermatology
    • Emergency
    • Endocrinology
    • Gastroenterology
    • Imaging and Intervention
    • Infectious Disease
    • Nephrology
    • Neurology
    • Obstetrics
    • Oncology
    • Ophthalmology
    • Pediatrics
    • Pharma
    • Preclinical
    • Psychiatry
    • Public Health
    • Pulmonology
    • Rheumatology
    • Surgery
  • Tools
    • EvidencePulse™
    • RVU Search
    • NPI Registry Lookup
  • Pharma
  • AI News
  • The Scan+
  • Classics™+
    • 2MM+ Online Access
    • Paperback and Ebook
  • Rewinds
  • Partners
    • License Content
    • Submit Press Release
    • Advertise with Us
  • Account
    • Subscribe
    • Sign-in
    • My account
SUBSCRIBE
2 Minute Medicine
Subscribe
Home All Specialties Chronic Disease

High-flow nasal therapy with room air and fan therapy provide modest relief of dyspnea in advanced cancer patients who are not hypoxemic

byPaary BalakumarandSimon Pan
January 12, 2026
in Chronic Disease, Imaging and Intervention, Oncology
Reading Time: 2 mins read
0
Share on FacebookShare on Twitter

1. In patients with advanced cancer who are not hypoxemic, high-flow nasal therapy using room air and simple fan therapy provide safe, similar, and modest relief of dyspnea.

2. Because both treatments are safe, feasible, and equally effective, the choice of therapy should be guided by patient comfort, preference, and ease of use.

Evidence Rating Level: 2 (Good) 

Dyspnea is a common and distressing symptom in patients with advanced cancer, and while airflow-based therapies can provide relief, the comparative role of high-flow nasal therapy (HFNT) with room air versus simple fan therapy in nonhypoxemic patients remains uncertain. This prospective, randomized, controlled crossover trial evaluated the efficacy and feasibility of HFNT with air compared with fan therapy in relieving dyspnea among adults with incurable cancer and oxygen saturation ≥88%. Thirty-six patients with moderate dyspnea (numeric rating scale [NRS] ≥3) were enrolled, and 28 completed both interventions. Participants received 30 minutes of HFNT with room air and 30 minutes of fan therapy in randomized order, separated by a washout period. Both interventions resulted in statistically significant but modest reductions in dyspnea. Median dyspnea scores decreased from 5.0 to 3.5 with HFNT and from 5.0 to 2.5 with fan therapy. The median change in dyspnea was −1.0 NRS points for both treatments, with no significant difference between them. Over half of patients reported subjective dyspnea relief and good adaptation to each therapy. Adverse events were minimal, and no serious events occurred. The study concludes that HFNT with room air offers no advantage over fan therapy for dyspnea relief in nonhypoxemic patients with advanced cancer. Both modalities are feasible, safe, and provide mild symptom relief, supporting individualized, preference-based selection.

Click here to read this study in the Journal of Pain and Symptom Management

Image: PD

RELATED REPORTS

Artificial intelligence predicts colorectal cancer in ulcerative colitis with 99% accuracy

2 Minute Medicine Rewind February 16, 2026

AstraZeneca moves to own multimodal oncology AI with Modella

©2026 2 Minute Medicine, Inc. All rights reserved. No works may be reproduced without expressed written consent from 2 Minute Medicine, Inc. Inquire about licensing here. No article should be construed as medical advice and is not intended as such by the authors or by 2 Minute Medicine, Inc. 

Tags: dyspneahigh-flow nasal cannula (HFNC)oncologypalliative caresymptom management
Previous Post

The preoperative combination of evolocumab and rosuvastatin may not reduce major adverse cardiovascular events

Next Post

2 Minute Medicine Rewind January 12th, 2026

RelatedReports

2MM: AI Roundup- AI Cancer Test, Smarter Hospitals, Faster Drug Discovery, and Mental Health Tech [May 2nd, 2025]
AI Roundup

Artificial intelligence predicts colorectal cancer in ulcerative colitis with 99% accuracy

February 20, 2026
Mutation linked with decrease in cutaneous diffuse large B-cell lymphoma
Weekly Rewinds

2 Minute Medicine Rewind February 16, 2026

February 16, 2026
Patients with advanced adenomas are at increased risk of developing colorectal cancer
AI Roundup

AstraZeneca moves to own multimodal oncology AI with Modella

January 21, 2026
2MM: AI Roundup- AI Cancer Test, Smarter Hospitals, Faster Drug Discovery, and Mental Health Tech [May 2nd, 2025]
AI Roundup

2MM: AI Roundup – Lilly and NVIDIA’s $1B AI lab, Illumina’s Billion Cell Atlas, AstraZeneca’s Modella deal, and Claude for Healthcare [Jan 19th, 2026]

January 19, 2026
Next Post
Contrast-enhanced computed tomography associated with high sensitivity to renal stone detection

2 Minute Medicine Rewind January 12th, 2026

2 Minute Medicine: Pharma Roundup: Price Hikes, Breakthrough Approvals, Legal Showdowns, Biotech Expansion, and Europe’s Pricing Debate [May 12nd, 2025]

2 Minute Medicine: Pharma Roundup – New oral gonorrhea antibiotic Nuzolvence (zoliflodacin), late‑December cardiovascular and oncology drug approvals, first targeted complement inhibitor therapy for HSCT‑TMA (Yartemlea), and antibody‑drug conjugate (ADC) safety concerns with ifinatamab deruxtecan (I‑DXd) [January 2026]

Patients with advanced adenomas are at increased risk of developing colorectal cancer

Large language models (LLMs) substantially improved patient comprehension of discharge summaries

2 Minute Medicine® is an award winning, physician-run, expert medical media company. Our content is curated, written and edited by practicing health professionals who have clinical and scientific expertise in their field of reporting. Our editorial management team is comprised of highly-trained MD physicians. Join numerous brands, companies, and hospitals who trust our licensed content.

Recent Reports

  • Poly-L-lysine-coated catheters are safe and well-tolerated in adults requiring short-term catheterization
  • Artificial intelligence predicts colorectal cancer in ulcerative colitis with 99% accuracy
  • Penpulimab and lenalidomide in combination with standard of care chemoimmunotherapy demonstrates promising safety and efficacy in diffuse large B-cell lymphoma
License Content
Terms of Use | Disclaimer
Cookie Policy
Privacy Statement (EU)
Disclaimer

© 2025 2 Minute Medicine, Inc. - Physician-written medical news.

  • Specialties
    • All Specialties, All Recent Reports
    • Cardiology
    • Chronic Disease
    • Dermatology
    • Emergency
    • Endocrinology
    • Gastroenterology
    • Imaging and Intervention
    • Infectious Disease
    • Nephrology
    • Neurology
    • Obstetrics
    • Oncology
    • Ophthalmology
    • Pediatrics
    • Pharma
    • Preclinical
    • Psychiatry
    • Public Health
    • Pulmonology
    • Rheumatology
    • Surgery
  • Tools
    • EvidencePulse™
    • RVU Search
    • NPI Registry Lookup
  • Pharma
  • AI News
  • The Scan
  • Classics™
    • 2MM+ Online Access
    • Paperback and Ebook
  • Rewinds
  • Partners
    • License Content
    • Submit Press Release
    • Advertise with Us
  • Account
    • Subscribe
    • Sign-in
    • My account
No Result
View All Result

© 2025 2 Minute Medicine, Inc. - Physician-written medical news.